Pharma major Ranbaxy Laboratories today said it has restarted production of generic cholesterol lowering drug Atorvastatin as it looks to resume supplies to the American market.
In November last year
Credit Suisse upgrades Ranbaxy Laboratories Ltd to "neutral" from "underperform".
The investment bank says the possible penalty related to the recall of generic Lipitor last year in the United states
Ranbaxy Laboratories has stopped production of its generic version of cholesterol lowering drug Lipitor until it investigates the issue of potential glass particles in certain lots, the US health regulator
Drug major Ranbaxy Laboratories today said it has launched Absorica capsules used in treating acne in the US market.
Ranbaxy Laboratories Inc (RLI) a wholly owned subsidiary
Ranbaxy Laboratories today said it has raised Rs 500 crore via issue of non-convertible debentures to be utilised for general corporate purposes.
"The company on November 23, 2012 has issued
Ranbaxy Laboratories Ltd India's top drugmaker by sales beat estimates with a Rs 7. 5 billion quarterly net profit on stronger demand for its generic drugs in its
Ranbaxy Laboratories has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market under an agreement with Daiichi Sankyo Inc. Ranbaxy Pharmaceuticals Inc (RPI), a wholly-owned
Drug major Ranbaxy Laboratories today said it has received approval from Malaysian authorities to set up its second manufacturing plant in the country at an investment of $40 million (around
Stay informed on our latest news!
